169 related articles for article (PubMed ID: 34027786)
1. Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
Haghpanah S; Hosseini-Bensenjan M; Sayadi M; Karimi M
Hemoglobin; 2021 Nov; 45(6):371-379. PubMed ID: 34027786
[TBL] [Abstract][Full Text] [Related]
2. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
Fattoum S
Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Cardiovascular Complications in Individuals with Sickle Cell Anemia and Other Hemoglobinopathies: A Systematic Review.
Lopes A; Dantas MT; Ladeia AMT
Arq Bras Cardiol; 2022 Dec; 119(6):893-899. PubMed ID: 36417618
[TBL] [Abstract][Full Text] [Related]
4. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
Jha AN; Mishra H; Verma HK; Pandey I; Lakkakula BVKS
Hemoglobin; 2018 Mar; 42(2):84-90. PubMed ID: 30200838
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Hemoglobinopathies (β-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
Mir SA; Alshehri BM; Alaidarous M; Banawas SS; Dukhyil AAAB; Alturki MK
Hemoglobin; 2020 Jan; 44(1):47-50. PubMed ID: 32091272
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobinopathies in the United Arab Emirates.
Baysal E
Hemoglobin; 2001 May; 25(2):247-53. PubMed ID: 11480786
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes.
Lee JX; Chieng WK; Lau SCD; Tan CE
Front Med (Lausanne); 2021; 8():757510. PubMed ID: 34722593
[TBL] [Abstract][Full Text] [Related]
8. Genetic Background of β-Thalassemia in Northeast Algeria with Assessment of the Thalassemia Severity Score and Description of a new β
Abdaoui W; Benouareth DE; Djenouni A; Renoux C; Grifi F; Gouri A; Athamnia F; Benalioua M; Joly P
Hemoglobin; 2019; 43(4-5):223-228. PubMed ID: 31603010
[TBL] [Abstract][Full Text] [Related]
9. Hb S/
Belisário AR; Carneiro-Proietti AB; Sabino EC; Araújo A; Loureiro P; Máximo C; Flor-Park MV; Rodrigues DDOW; Ozahata MC; McClure C; Mota RA; Gomes Moura IC; Custer B; Kelly S;
Hemoglobin; 2020 Jan; 44(1):1-9. PubMed ID: 32172616
[TBL] [Abstract][Full Text] [Related]
10. Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.
Stratopoulos A; Kolliopoulou A; Karamperis K; John A; Kydonopoulou K; Esftathiou G; Sgourou A; Kourakli A; Vlachaki E; Chalkia P; Theodoridou S; Papadakis MN; Gerou S; Symeonidis A; Katsila T; Ali BR; Papachatzopoulou A; Patrinos GP
Pharmacogenomics; 2019 Jul; 20(11):791-801. PubMed ID: 31393228
[No Abstract] [Full Text] [Related]
11. Prenatal diagnosis of sickle cell anemia and beta-thalassemia in southern Turkey.
Cürük MA; Zeren F; Genç A; Ozavci-Aygün S; Kilinç Y; Aksoy K
Hemoglobin; 2008; 32(6):525-30. PubMed ID: 19065329
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis of hemoglobinopathies in Turkey: Hacettepe experience.
Gürgey A; Beksaç S; Gümrük E; Cakar N; Mesçi L; Altay S; Oner C; Altay C
Pediatr Hematol Oncol; 1996; 13(2):163-6. PubMed ID: 8721031
[TBL] [Abstract][Full Text] [Related]
13. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates.
Alkindi S; Al Zadjali S; Al Madhani A; Daar S; Al Haddabi H; Al Abri Q; Gravell D; Berbar T; Pravin S; Pathare A; Krishnamoorthy R
Hemoglobin; 2010 Jan; 34(2):135-44. PubMed ID: 20353348
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China.
Ding ZY; Shen GS; Zhang S; He PY
Hemoglobin; 2016 Sep; 40(5):304-309. PubMed ID: 27615034
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
Varelas C; Gavriilaki E; Sakellari I; Klonizakis F; Anagnostopoulos A; Tsapas A; Vlachaki E
Hemoglobin; 2022 Mar; 46(2):143-145. PubMed ID: 36100258
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological profile of hemoglobinopathies: a cross-sectional and descriptive index case study].
Dahmani F; Benkirane S; Kouzih J; Woumki A; Mamad H; Masrar A
Pan Afr Med J; 2017; 27():150. PubMed ID: 28904678
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobinopathies in the Çukurova Region and Neighboring Provinces.
Yuzbasioglu Ariyurek S; Yildiz SM; Yalin AE; Guzelgul F; Aksoy K
Hemoglobin; 2016 Jun; 40(3):168-72. PubMed ID: 26984585
[TBL] [Abstract][Full Text] [Related]
18. Study on the Role of Polymorphisms of the SOX-6 and MYB Genes and Fetal Hemoglobin Levels in Sicilian Patients with β-Thalassemia and Sickle Cell Disease.
Listì F; Sclafani S; Agrigento V; Barone R; Maggio A; D'Alcamo E
Hemoglobin; 2018 Mar; 42(2):103-107. PubMed ID: 30200835
[TBL] [Abstract][Full Text] [Related]
19. "Minor" hemoglobinopathies: a risk factor for asthma.
Palma-Carlos AG; Palma-Carlos ML; Costa AC
Eur Ann Allergy Clin Immunol; 2005 May; 37(5):177-82. PubMed ID: 15984316
[TBL] [Abstract][Full Text] [Related]
20. Care of patients with hemoglobin disorders during the COVID-19 pandemic: An overview of recommendations.
Taher AT; Bou-Fakhredin R; Kreidieh F; Motta I; De Franceschi L; Cappellini MD
Am J Hematol; 2020 Aug; 95(8):E208-E210. PubMed ID: 32394480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
